Cytokines and Growth Factors in Blood Transfusion

Cytokines and Growth Factors in Blood Transfusion

Author: C.Th. Smit Sibinga

Publisher: Springer Science & Business Media

Published: 2012-12-06

Total Pages: 291

ISBN-13: 1461311373

DOWNLOAD EBOOK

Cytokines are cellular growth factors which also provide communication between cells and their milieu. This clearly is an exciting area in modern medicine that will have significant impact on various facets of transfusion. Erythropoietin therapy stimulates red cell production while thrombopoietin seems to positively affect megakaryopoiesis and can be an added armamentarium for the thrombocytopenic patient. Using haematnopoietic growth factors, stem cells could be mobilized early to the peripheral blood for collection and subsequent transplantation into haemato-oncology patients instead of bone marrow transplantation. Using a cocktail of cytokines in cell culture, stem cells could be expanded and selected for therapy. Cytokines and growth factors can even be modified, which may lead to successful gene therapy in malignancies, including solid tumour vaccines. However, the presence of cytokines in certain blood products could have biological effects following transfusion, although its clinical relevance needs to be ascertained. There is much potential for the use of cytokines in the treatment of infections. Early diagnostic methods are now available to monitor their levels and relevance. It is likely that cytokines will increasingly play a role in therapy and could develop our fundamental knowledge about the development of T-cells. An ethical dilemma remains, however, regarding the use of cytokines in healthy donors for harvesting suitable specific cells. Longer clinical observation will be necessary to gather the necessary information. Cytokines and growth factors in blood transfusion was the theme of the 21st International Symposium in Blood Transfusion, where twenty clinicians and scientists, experts in their own fields, were invited to update the above information. Their findings are presented in four sections in this volume: Fundamental aspects - cytokines in development of T-cells, growth factors in haematopoiesis, growth factor receptors and signal transduction, cytokine response in platelet and whole blood transfusions. Function, production and diagnosis – laboratory diagnostics of cytokines and growth factors, cytokines in blood components, cytokines and growth factors in cell expansions, cytokines for genetic modification towards gene therapy, progenitor cells from healthy donors. Application in clinical medicine – clinical relevance of cytokines in transfusion products, cytokines and growth factors in solid tumours, gene therapy in malignancies, vaccine strategies inducing T-cell immunity against tumours, cytokines in the treatment of infections, thrombopoietin and megakaryopoiesis. Future potential use in transfusion medicine – erythropoietin, immunotherapy, ethical aspects of the use of cytokines and growth factors in donors, potential of cytokines and growth factors in transfusion medicine.


Clinical Applications of Cytokines and Growth Factors

Clinical Applications of Cytokines and Growth Factors

Author: John R. Wingard

Publisher: Springer Science & Business Media

Published: 2012-12-06

Total Pages: 424

ISBN-13: 1461550130

DOWNLOAD EBOOK

The hematopoietic system plays roles that are crucial for survival of the host: delivery of oxygen to tissues, arrest of accidental blood leaking from blood vessels, and fending off of invading microbes by humoral, cell-mediated, and phagocytic immunity. The activity of the hematopoietic system is staggering: daily, a normal adult produces approximately 2.5 billion erythrocytes, 2.5 billion platelets, and 1 billion granulocytes per kilogram of body weight. This production is adjusted in a timely fashion to changes in actual needs and can vary from nearly none to many times the normal rate depending on needs which vary from day to day, or even minute to minute. In response to a variety of stimuli, the cellular components of the blood are promptly increased or decreased in production to maintain appropriate numbers to optimally protect the host from hypoxia, infection, and hemorrhage. How does this all happen and happen without over or under responding? There has been extraordinary growth in our understanding ofhematopoiesis over the last two decades. Occupying center stage is the pluripotent stern cell and its progeny. Hematopoietic stern cells have been characterized by their capacity for self renewal and their ability to proliferate and differentiate along multiple lineages. Few in number, the stern cell gives rise to all circulating neutrophils, erythrocytes, lymphoid cells, and platelets. In hematopoietic transplantation, the stern cell is capable of restoring long-term hematopoiesis in a lethally irradiated host.


Cytokines in the Treatment of Hematopoietic Failure

Cytokines in the Treatment of Hematopoietic Failure

Author: Arnold Ganser

Publisher: CRC Press

Published: 1998-09-03

Total Pages: 416

ISBN-13: 9780824701932

DOWNLOAD EBOOK

Written by world experts in the field, this book presents up-to-date, in-depth coverage of hematopoietic growth factors and related cytokines that are currently being developed or used for managing congenital and acquired forms of chronic cytopenias. Summarizes important clinical trial data in a convenient tabulated format and provides fundamental knowledge on hematopoiesis physiology and regulation! Facilitating rational decision making and cost-effective treatment strategies, this clinically and disease-oriented work describes as well as assesses the benefits and limitations of hematopoietic growth factor and cytokine use in graft failure peripheral-blood progenitor cell transplantation chemotherapy- and radiotherapy-induced cytopenias in patients with solid tumors and hematological malignancies, including leukemias and myelodysplastic syndromes cytopenic states related to infectious conditions such as AIDS ex vivo expansion of hematopoietic progenitor cells post-operative procedures for bone marrow transplantation renal failure the neonate transfusion medicine and more! Supplemented with literature citations and drawings, Cytokines in the Treatment of Hematopoietic Failure is an essential resource for hematologists, oncologists, internists, radiotherapists, pediatricians, neonatologists, infectious disease specialists, nephrologists, immunologists, transfusion medicine specialists, researchers in pharmaceutical companies, and graduate and medical school students in these disciplines.


Growth Factors, Differentiation Factors, and Cytokines

Growth Factors, Differentiation Factors, and Cytokines

Author: Andreas Habenicht

Publisher: Springer Science & Business Media

Published: 2012-12-06

Total Pages: 484

ISBN-13: 3642748562

DOWNLOAD EBOOK

Leading international experts contribute to this selection of reviews covering the merging fields of growth factors, differentiation factors, and cytokines. These appear to play fundamental roles in a wide variety of physiological and pathophysiological processes that include the regulation of growth in normal and malignant cells, embryogenesis, the immune response, wound healing, inflammation, and atherogenesis. The major aspects of recent research and development are discussed, providing an important update in this pioneering field.


Blood Cell Biochemistry

Blood Cell Biochemistry

Author: Anthony D. Whetton

Publisher: Springer Science & Business Media

Published: 1996-08-31

Total Pages: 460

ISBN-13:

DOWNLOAD EBOOK

Volume 7 explores the role of receptors and growth factors in the control of hematopoiesis and the immune system. This work features color plates and numerous illustrations.


Handbook of Growth Factors

Handbook of Growth Factors

Author: Enrique Pimentel

Publisher: CRC Press

Published: 1994-06-02

Total Pages: 392

ISBN-13: 9780849325076

DOWNLOAD EBOOK

Handbook of Growth Factors, Volume III is devoted to hematopoiesis and its regulation by endogenous factors with growth stimulatory and growth inhibitory properties. The book provides detailed discussions on signaling agents related to the regulation of hematopoiesis, including the interleukins, the colony-stimulating factors, the interferons, the tumor necrosis factors, the erythropoietic growth factors, the platelet-derived growth factor, the leukemia inhibitory factor, and the transferrins. The structure and function of each factor is covered in detail, as well as its receptor and postreceptor mechanism of action and its possible role in neoplastic processes. The book also explores the present state of the knowledge about megakaryocyte growth factors and macrophage-derived growth factors.


Alternative Approaches to Human Blood Resources in Clinical Practice

Alternative Approaches to Human Blood Resources in Clinical Practice

Author: Cees Smit Sibinga

Publisher: Springer Science & Business Media

Published: 1998-09-30

Total Pages: 280

ISBN-13: 9780792383055

DOWNLOAD EBOOK

Currently blood is a volatile issue. The safety of blood and the quantification of transfusion risks have been dominant themes that have stimulated the development of alternative approaches in this rapidly developing area. In clinical medicine conventional blood and its components are used in supportive therapies dependent on the choice of apparent uncritical trigger factors. A compounding factor is depth of prospective clinical trials for evidence. Such trials in critical care areas would be of enormous value, not only in recording adverse effects and under-transfusion, but also indicating the value of decision analysis and cost-effectiveness in transfusion practice. Alternative approaches include the use of cytokines, growth factors, humanised monoclonal antibodies, recombinant plasma factors, and buffy coat derived natural human interferons. These are being increasingly implemented in the clinic. Solutions for oxygen transport are being developed and fibrinogen coated microcapsules are being investigated for thrombocytopenia. In surgical patients, various crystalloid and colloid combinations are explored as volume replacements. To avoid allogeneic transfusions, beneficial blood saving methods include various strategies, such as autologous deposits, normovolemic haemodilution and various agents including aprotinin, tranecamic acid, desmopressin and erythropoietin, but their use in hospital shows considerable variations. That umbilical cord blood could be a significant source of allogeneic stem cells in related and unrelated transplantation is illustrated by the increasing number of cord blood banks in Europe and elsewhere. Future blood resources are likely to face several challenges: immediate challenges relate to increased regulatory and political oversights; intermediate solutions would offer some improvements in public health and alleviate public fear but probably not address the economic challenges thrust upon the medical care system. As we approach the year 2000, the major concerns about transfusion medicine remain its logistics, safety and effectiveness. This theme is presented in the proceedings of the 22nd International Symposium on Blood Transfusion, developed in 21 up-to-date topics, collected and discussed in four sections. This book will be of timely value to students, professionals and all others interested or involved in the field of transfusion medicine, whether clinical or related.